GSK cut its full-year vaccine sales outlook after key shots for respiratory syncytial virus and shingles missed expectations ...
GSK stock plunged Wednesday after sales of its RSV vaccine, Arexvy, skidded and widely missed Wall Street's expectations.
GSK remains on fairly stable financial footing, with a debt/EBITDA ratio of 2.1 at the end of 2023 and Haleon taking on close to GBP 10 billion of GSK's debt in the 2022 divestment. With the improving ...
Delivery of immunomodulating compounds to the genital mucosa requires considerable investigation into their impact on HIV-1 infections.
Asphalt shingles can show signs of wear long before they’ve exceeded their life span. If you don’t need a new roof but want a quick refresh, consider painting your roofing shingles.
Long-term, low-dose antiviral treatment reduces the risk for potentially vision-damaging bouts of inflammation and infection, as well as pain, which occur when shingles affects the eye ...
That’s what he did in his new paper to test the emerging idea that dementia can be caused by the shingles virus. Social scientists have been using these methods for decades, but very few ...
After you get chickenpox, the virus stays in your body and can cause shingles, a painful rash, later in life. A shingles vaccine is available for adults over 50 or those over 19 with a weakened ...
Future Virology. 2014;9(2):161-171. Solid organ transplant (SOT) recipients with influenza disease are at high risk for severe influenza and so these individuals benefit from annual immunization ...
Copyright 2024 The Associated Press. All Rights Reserved. In this photo provided by Johns Hopkins Medicine, Dr. Dorry Segev, right, performs the first U.S. transplant ...
Kidney transplantation from donors with human immunodeficiency virus (HIV) to recipients with HIV is an emerging practice. It has been performed since 2016 under the U.S. congressional HIV Organ ...
Researchers at Fred Hutchinson Cancer Center, led by Dr. Julie McElrath, Director of the Vaccine and Infectious Disease Division, have found a new way to train our immune system to make antibodies ...